Characteristics and outcomes of COVID-19 in heart transplantation recipients in the Netherlands.

ABSTRACT:

Background

Immunocompromised patients are at high risk of complicated severe acute respiratory coronavirus 2 infection. The aim of this retrospective study was to describe the characteristics and outcomes of heart transplantation (HTx) recipients with coronavirus disease 2019 (COVID-19) in the Netherlands.

Methods

HTx patients from one of the three HTx centres in the Netherlands with COVID-19 (proven by positive reverse-transcription polymerase chain reaction or serology test result) between February 2020 and June 2021 were included. The primary endpoint was all-cause mortality and the secondary endpoint was disease severity.

Results

COVID-19 was diagnosed in 54/665 HTx patients (8%), with a mean (± standard deviation (SD)) time after HTx of 11 ± 8 years. Mean (± SD)

SUBMITTER: Muller SA 

PROVIDER: S-EPMC9454385 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature